Literature DB >> 23483478

Expression regulation and function of NLRC5.

Yikun Yao1, Youcun Qian.   

Abstract

The NOD like receptors (NLRs), a class of intracellular receptors that respond to pathogen attack or cellular stress, have gained increasing attention. NLRC5, the largest member of the NLR protein family, has recently been identified as a critical regulator of immune responses. While NLRC5 is constitutively and widely expressed, it can be dramatically induced by interferons during pathogen infections. Both in vitro and in vivo studies have demonstrated that NLRC5 is a specific and master regulator of major mistocompatibility complex (MHC) class I genes as well as related genes involved in MHC class I antigen presentation. The expression of MHC class I genes is regulated by NLRC5 in coordination with the RFX components through an enhanceosome-dependent manner. And the involvement of NLRC5 in MHC class I mediated CD8+ T cell activation, proliferation and cytotoxicity is proved to be critical for host defense against intracellular bacterial infections. Nevertheless, the role of NLRC5 in innate immunity remains to be further explored. Here, we review the research advances on the structure, expression regulation and function of NLRC5.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483478      PMCID: PMC4875496          DOI: 10.1007/s13238-012-2109-3

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  51 in total

1.  CREB regulates MHC class II expression in a CIITA-dependent manner.

Authors:  C S Moreno; G W Beresford; P Louis-Plence; A C Morris; J M Boss
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Authors:  Andreas Neerincx; Katja Lautz; Maureen Menning; Elisabeth Kremmer; Paola Zigrino; Marianna Hösel; Hildegard Büning; Robert Schwarzenbacher; Thomas A Kufer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.

Authors:  Andreas Neerincx; Galaxia M Rodriguez; Viktor Steimle; Thomas A Kufer
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

4.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

5.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.

Authors:  J C Shepherd; T N Schumacher; P G Ashton-Rickardt; S Imaeda; H L Ploegh; C A Janeway; S Tonegawa
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

Review 6.  Several genes in the extended human MHC contribute to predisposition to autoimmune diseases.

Authors:  Benedicte A Lie; Erik Thorsby
Journal:  Curr Opin Immunol       Date:  2005-10       Impact factor: 7.486

7.  NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.

Authors:  Torsten B Meissner; Amy Li; Amlan Biswas; Kyoung-Hee Lee; Yuen-Joyce Liu; Erkan Bayir; Dimitrios Iliopoulos; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

8.  Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport.

Authors:  Margarita M Camacho-Carvajal; Sebastian Klingler; Felix Schnappauf; Sandra B Hake; Viktor Steimle
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

9.  NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.

Authors:  Irving C Allen; Justin E Wilson; Monika Schneider; John D Lich; Reid A Roberts; Janelle C Arthur; Rita-Marie T Woodford; Beckley K Davis; Joshua M Uronis; Hans H Herfarth; Christian Jobin; Arlin B Rogers; Jenny P-Y Ting
Journal:  Immunity       Date:  2012-04-12       Impact factor: 31.745

10.  NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens.

Authors:  Paras K Anand; R K Subbarao Malireddi; John R Lukens; Peter Vogel; John Bertin; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

View more
  15 in total

Review 1.  NLRC5: new cancer buster?

Authors:  Feng Tang; Yadi Xu; Bing Zhao
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

2.  NLRC5 Mediates IL-6 and IL-1β Secretion in LX-2 Cells and Modulated by the NF-κB/Smad3 Pathway.

Authors:  Tao Xu; Ming-ming Ni; Cheng Huang; Xiao-ming Meng; Ying-hua He; Lei Zhang; Jun Li
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway.

Authors:  Lin Li; Tao Xu; Cheng Huang; Yunyun Peng; Jun Li
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.

Authors:  Xiaoyu Li; Fuchun Guo; Yongmei Liu; Hui-Jiao Chen; Feng Wen; Binwen Zou; Dan Li; Qin Qin; Xiaoke Liu; Yali Shen; Yongsheng Wang
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

5.  Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.

Authors:  Peter A Fasching; Duan Liu; Steve Scully; Lothar Häberle; Richard M Weinshilboum; Liewei Wang; James N Ingle; Paulo C Lyra; Brigitte Rack; Alexander Hein; Arif B Ekici; Andre Reis; Andreas Schneeweiss; Hans Tesch; Tanja N Fehm; Georg Heinrich; Matthias W Beckmann; Matthias Ruebner; Hanna Huebner; Diether Lambrechts; Ebony Madden; Jess Shen; Jane Romm; Kim Doheny; Gregory D Jenkins; Erin E Carlson; Liang Li; Brooke L Fridley; Julie M Cunningham; Wolfgang Janni; Alvaro N A Monteiro; Daniel J Schaid
Journal:  Clin Cancer Res       Date:  2022-08-02       Impact factor: 13.801

6.  Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.

Authors:  Xiang Liu; Lingdan Yin; Mei Xue; Jianfei Chen; Liang Li; Fang Fu; Li Feng; Pinghuang Liu
Journal:  J Virol       Date:  2022-03-21       Impact factor: 6.549

7.  Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.

Authors:  Patrick Vianna Garcia; Fábio Rodrigues Ferreira Seiva; Amanda Pocol Carniato; Wilson de Mello Júnior; Nelson Duran; Alda Maria Macedo; Alexandre Gabarra de Oliveira; Rok Romih; Iseu da Silva Nunes; Odilon da Silva Nunes; Wagner José Fávaro
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

Review 8.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

9.  Exploring transcriptomic diversity in muscle revealed that cellular signaling pathways mainly differentiate five Western porcine breeds.

Authors:  Magali SanCristobal; Florian Rohart; Christine Lascor; Marcel Bouffaud; Lidwine Trouilh; Pascal G P Martin; Yannick Lippi; Thierry Tribout; Thomas Faraut; Marie-José Mercat; Denis Milan; Laurence Liaubet
Journal:  BMC Genomics       Date:  2015-12-12       Impact factor: 3.969

10.  Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.

Authors:  Tünde Fekete; Dora Bencze; Attila Szabo; Eszter Csoma; Tamas Biro; Attila Bacsi; Kitti Pazmandi
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.